Fingerprint
Dive into the research topics of 'Clinical Experience With 75-mg Dose of Erlotinib for Mutated Metastatic EGFR Non-small Cell Lung Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Clinical Experience With 75-mg Dose of Erlotinib for Mutated Metastatic EGFR Non-small Cell Lung Cancer
Osvaldo Aren, Suraj Samtani, Micahel Frelinghuysen, Mauricio Burotto
Research output: Contribution to journal › Article › peer-review